Project

APD334-206 Etrasimod

Completed ยท 2020 until 2022

Type
Clinical Studies
Range
Multicentric, KSSG as participating partner
Units
Status
Completed
Start Date
2020
End Date
2022
Financing
Industry
Brief description/objective

A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Assess
the Safety and Efficacy of Etrasimod in Adult Subjects with Eosinophilic
Esophagitis